Own NIB shares? Here are the key dates for 2026

NIB has released its corporate calendar, including dividend dates, for 2026.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Australians are facing rising premiums for private health insurance with fewer benefits, as highlighted by the AMA's 2025 report which criticises insurers for delivering poor value despite strong profits.
  • NIB Holdings reported increased revenue in FY25, but with a decrease in group underlying profit, although net profit after tax grew by 9.4%.
  • In 2026, important NIB investor dates include announcements for half-year results and dividends on 23 February and full-year results on 24 August, with dividends scheduled for April and October.

The NIB Holdings Ltd (ASX: NHF) share price is down 2.47% to $6.71 on Friday.

A scathing new report shows Australians are paying more for private health insurance policies but receiving fewer benefits.

The key benefits of private health insurance include help with costs, the ability to choose your doctor, shorter waiting periods for elective surgery, and a tax break for higher income earners, as having insurance means they don't have to pay the Medicare surcharge.

The Australian Medical Association (AMA) released its 2025 Private Health Insurance Report Card today.

The report shows consumers are feeling increasingly dissatisfied with the value for money they're getting while insurers post big profits.

For FY25, NIB reported higher revenue, lower underlying group profit, and higher net profit after tax (NPAT).

Revenue was $3.6 billion in FY25, up from $3.3 billion in FY24. Group underlying operating profit was $239.2 million, down from $257.5 million in FY24, and NPAT was $198.6 million, up 9.4% from $181.6 million in FY24.

A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.

Image source: Getty Images

What did the AMA say about private health insurance?

AMA President Dr Danielle McMullen said the report "reveals a system increasingly failing to deliver value for money".

Dr McMullen said:

Premiums have risen sharply, outpacing inflation, wage growth, and Medicare indexation — while coverage has narrowed.

Sixty-eight per cent of hospital policies now contain exclusions, meaning many Australians are paying more, but are covered for less.

The report found that Australian consumers were dropping gold level policies in favour of cheaper silver and bronze packages.

Since March 2020, the number of gold health insurance policies has fallen by 360,000 while the overall number of policies has risen 640,000.

Dr McMullen commented:

The tiered product system introduced in 2020 — basic, bronze, silver, and gold — was designed to simplify choices but has instead created confusion and contributed to underinsurance.

Gold-tier policies, which provide the most comprehensive coverage, are particularly susceptible to phoenixing — a term used when insurers close an existing policy and replace it with a nearly identical one at a higher price — a practice that has become increasingly common.

Key dates for NIB shares investors in 2026

Looking ahead to 2026, here are the important dates for NIB shares investors to note.

NIB will announce its FY26 half-year results and interim dividend on 23 February.

The ex-dividend date for the interim NIB dividend will be 5 March.

If you'd like NIB to use your dividends to reinvest in more shares, you'll need to enrol in the dividend reinvestment plan (DRP) by 9 March.

NIB shareholders will receive their dividends on 8 April.

The private health insurer will announce its FY26 full-year results and final dividend on 24 August.

The ex-dividend date for the final NIB dividend will be 3 September.

The DRP deadline will be 7 September.

NIB will pay its shareholders on 7 October.

The insurer will hold its annual general meeting on 11 November.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

After a 30% 2026 slide, Pro Medicus shares are rocketing again

Pro Medicus shares jump after another major contract win.

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Healthcare Shares

Could the CSL share price reach $200 in 2026?

The biotech's shares have had a tough run, but the long-term story may not be broken.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Pro Medicus announces $23m US contract

Pro Medicus has signed a $23 million, five-year cloud imaging contract with University of Maryland Medical System.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

2 classy ASX healthcare stocks to buy before the next market surge

If sentiment shifts, these global powerhouses could lead the rally.

Read more »

Two people jump and high five above a city skyline.
Healthcare Shares

Why rebounding Telix shares could still rise 40%

Bell Potter doesn't think it is too late to buy this stock.

Read more »

Female in elegant outfit smiling and gesturing victory with hands.
Healthcare Shares

Are Telix shares a buy after flying 40% higher in March?

Telix shares are up another 5.3% on Tuesday.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces.
Healthcare Shares

Down 30% today, is it time to buy into this beaten-down biotech share?

While there's been bad news, this company has more irons in the fire.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

What's the impact of US tariffs on Aussie drugmakers CSL and Mayne Pharma?

Is the US' bark worse than its bite?

Read more »